logo
Select company
Select metric
$ -2.86MNet Cash Flow - Financing
VS
Market
52
Sector
77
Industry
92
History
92
$ 2.36Close
$ 2 - $ 2.7 52-Week Range
Ticker Information

Ticker

ORMP

Company Name

ORAMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORAMED PHARMACEUTICALS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ORMP - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ -2.86M
3/31/2025$ -33.04M
12/31/2024$ -52.04M
9/30/2024$ -75.84M
6/30/2024$ -2K
3/31/2024$ 30.55M
12/31/2023$ 51.98M
9/30/2023$ 81.15M
6/30/2023$ 10.92M
3/31/2023$ 10.92M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 23.79M.
  • Over the past 5 years, ORAMED PHARMACEUTICALS INC's average CF - Financing has been $ 28.36M.
  • The median CF - Financing for ORAMED PHARMACEUTICALS INC during this period was $ 24.07M
  • ORAMED PHARMACEUTICALS INC reached its highest CF - Financing over the past 5 years at $ 162.87M.
  • The lowest CF - Financing recorded by ORAMED PHARMACEUTICALS INC in the same timeframe $ -75.84M

ORAMED PHARMACEUTICALS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
NTRB : NUTRIBAND INC $ 5.19MOTLK : OUTLOOK THERAPEUTICS INC $ 33.31MCNTB : CONNECT BIOPHARMA HOLDINGS LTD $ 436KPYXS : PYXIS ONCOLOGY INC $ 1.64MBTAI : BIOXCEL THERAPEUTICS INC $ 18.07MVTGN : VISTAGEN THERAPEUTICS INC $ 4.61MDTIL : PRECISION BIOSCIENCES INC $ 25.64MLGVN : LONGEVERON INC $ 13.48MPLUR : PLURI INC $ 9.53MADVM : ADVERUM BIOTECHNOLOGIES INC $ 359K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

ORMP - Net Cash Flow - Financing, Last 5 years

$ -75.84M

Minimum

Sep 30, 2024

$ 162.87M

Maximum

Dec 31, 2021

$ 28.36M

Average

$ 24.07M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.25M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.25M